title: [Loss of hbs antigen after treatment with analogues: infrequent but stable and beneficial].
authors.forename: Philippe
authors.initials: P
authors.lastname: Chanson
authors.forename: Alexandre
authors.initials: A
authors.lastname: Pariente
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D044466:Asian People; D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000821:virology; D015331:Cohort Studies; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006510:Hepatitis B Antibodies / Q000097:blood; D006511:Hepatitis B Antigens / Q000097:blood*; D019694:Hepatitis B, Chronic / Q000097:blood* / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000453:epidemiology / Q000821:virology; D008113:Liver Neoplasms / Q000453:epidemiology / Q000821:virology; D011379:Prognosis; D056910:Republic of Korea; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; D006510:Hepatitis B Antibodies; D006511:Hepatitis B Antigens; D019259:Lamivudine; C413685:entecavir; D006147:Guanine